Dashboard
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 14.33% and Operating profit at -3.91% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 7.46% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 14.33% and Operating profit at -3.91% over the last 5 years
3
Negative results in Sep 25
4
With ROE of 2.05%, it has a expensive valuation with a 1.79 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
CNY 4,033 Million (Small Cap)
88.00
NA
0.65%
1.05
1.83%
1.69
Revenue and Profits:
Net Sales:
941 Million
(Quarterly Results - Mar 2026)
Net Profit:
33 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
21.84%
0%
21.84%
6 Months
30.9%
0%
30.9%
1 Year
25.48%
0%
25.48%
2 Years
27.1%
0%
27.1%
3 Years
-17.12%
0%
-17.12%
4 Years
23.17%
0%
23.17%
5 Years
-37.09%
0%
-37.09%
Shenzhen Sunnypol Optoelectronics Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
14.33%
EBIT Growth (5y)
-3.91%
EBIT to Interest (avg)
4.90
Debt to EBITDA (avg)
3.52
Net Debt to Equity (avg)
0.83
Sales to Capital Employed (avg)
0.59
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
38.23%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.50%
ROE (avg)
7.46%
Valuation key factors
Factor
Value
P/E Ratio
88
Industry P/E
Price to Book Value
1.79
EV to EBIT
63.84
EV to EBITDA
21.14
EV to Capital Employed
1.40
EV to Sales
2.14
PEG Ratio
NA
Dividend Yield
0.61%
ROCE (Latest)
2.20%
ROE (Latest)
2.05%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
941.00
1,044.90
-9.94%
Operating Profit (PBDIT) excl Other Income
61.30
76.30
-19.66%
Interest
13.70
14.90
-8.05%
Exceptional Items
-3.20
-1.20
-166.67%
Consolidate Net Profit
33.30
2.10
1,485.71%
Operating Profit Margin (Excl OI)
65.10%
9.50%
5.56%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -9.94% vs 8.45% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 1,485.71% vs -70.00% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
3,683.40
2,581.50
42.68%
Operating Profit (PBDIT) excl Other Income
375.80
261.40
43.76%
Interest
63.70
37.20
71.24%
Exceptional Items
4.50
0.20
2,150.00%
Consolidate Net Profit
46.80
68.40
-31.58%
Operating Profit Margin (Excl OI)
35.30%
33.70%
0.16%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 42.68% vs 25.24% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -31.58% vs 59.44% in Dec 2024
About Shenzhen Sunnypol Optoelectronics Co., Ltd. 
Shenzhen Sunnypol Optoelectronics Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






